Clinical Trial Update: Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating prophylactic tranexamic acid to reduce postpartum hemorrhage. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Systemic Autoimmune Diseases

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: RenJi Hospital | Conditions: Postpartum Hemorrhage, Systemic Autoimmune Diseases | Phase 4 | Status: RECRUITING